Biglycan
| GO Term | Evidence Code | Reference |
|---|---|---|
| bone development |
|
|
| articular cartilage development |
|
|
| GO Term | Evidence Code | Reference |
|---|---|---|
| extracellular region | ||
| extracellular region | ||
| obsolete extracellular space |
|
|
| cell surface | ||
| transport vesicle |
| GO Term | Evidence Code | Reference |
|---|---|---|
| glycosaminoglycan binding | ||
| cytokine binding | ||
| extracellular matrix binding |
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 42 |
|
|
||
| 48 |
|
|
||
| 181 |
|
|
||
| 199 |
|
|
||
| 271 |
|
|
||
| 312 |
|
|
| Pathway Name | Organism |
|---|---|
| A tetrasaccharide linker sequence is required for GAG synthesis | Bos taurus |
| CS/DS degradation | Bos taurus |
| Chondroitin sulfate biosynthesis | Bos taurus |
| Dermatan sulfate biosynthesis | Bos taurus |
| ECM proteoglycans | Bos taurus |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026